Protalix BioTherapeutics logo

Protalix BioTherapeutics

PLX | AMEX
Chart Builder DCF Calculator
$3.03
-$0.02 (-0.66%)
At close: Nov 16, 2026, 4:00 PM ET
$2.98
-$0.05 (-1.65%)
After-hours: Nov 16, 2026, 7:17 PM ET
-0.66%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
87
+3.0 pts
Fundamentals Excellent
Market Sentiment Neutral
Moat Narrow
Sector Rank #3/1021 (Top 1%)

Key Statistics

Market Data

Market Cap $255.49M
1D Range
2.96 3.07
52W Range
1.67 3.15

Valuation (TTM)

PE 12.12
PB 3.17
EV/EBITDA 7.57

Valuation (NTM)

Forward PE 10.89
Forward PEG 0.01
Price Target $6.00
Loading financial charts...

Profile

Protalix BioTherapeutics, Inc., a biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based p...

Sector Healthcare
Industry Biotechnology
Employees 226
IPO Date May 15, 1998
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 10, 2026
EPS
$0.05
Beat +350.00%
REV
$21.93M
Beat +76.53%
Next Earnings
Mar 17, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
1
Consensus
Buy
Price Target
$6.00
Upside
+98.02%
Buy (1)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.